Stéphane Postic
Financieel Directeur/CFO bij MEDINCELL S.A.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Sabri Markabi | M | - | 7 jaar | |
| Christophe Douat | M | 60 | 21 jaar | |
| Grace Kim | M | - | 1 jaar | |
| Julie Alimi | F | - | 3 jaar | |
| Philippe Guy | M | - | 14 jaar | |
| Antoine Andremont | M | - |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | 24 jaar |
| David Heuzé | M | - | 9 jaar | |
| Adolfo Lopez-Noriega | M | - | 9 jaar | |
| Franck Pouzache | M | - | 4 jaar | |
| Pierre-Alain Bandinelli | M | - |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | - |
| Nicolas Merigeau | M | - | - | |
| Christophe Roberge | M | - | 16 jaar | |
| Elisabeth Kogan | F | - | 4 jaar | |
| Sébastien Magnat | M | - | 8 jaar | |
| Sébastien Enault | M | - | - | |
| Richard Malamut | M | 64 | 2 jaar | |
| Virginie Lleu | F | - | 8 jaar | |
| Tone Kvåle | F | 55 | 2 jaar | |
| Nicolas Gourgues | M | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Anh Nguyen | M | - | 21 jaar | |
| Mohammed Khoso Baluch | M | 66 |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Frankrijk | 21 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Stéphane Postic
- Persoonlijk netwerk